William Maughan
Stock Analyst at Canaccord Genuity
(3.07)
# 451
Out of 5,240 analysts
29
Total ratings
54.55%
Success rate
50.97%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BioNTech | Maintains: Strong Buy | 171 172 | 115.03 | 49.04% | 13 | Nov 27, 2024 | |
Harpoon Therapeutics | Maintains: Buy | 80 40 | n/a | n/a | 3 | Sep 14, 2023 | |
Y-mAbs Therapeutics | Maintains: Buy | 20 18 | 6.58 | 173.56% | 2 | Mar 31, 2023 | |
Xencor | Maintains: Buy | 48 42 | 19.64 | 113.85% | 6 | Feb 24, 2023 | |
Neoleukin Therapeuti... | Downgrades: Hold | 200 20 | n/a | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 | 5.38 | 197.4% | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 60 | 14.59 | 311.24% | 1 | Jul 6, 2022 |